Nanalysis Scientific (NSCI.V) Stock Price

Nanalysis Scientific Price

OTC·CLOSED
0.11
​
Market closed

Revenue has compounded at 25.4% per year over the past 9 years to 40.13 M CAD. Nanalysis Scientific's net margin stands at -14.1%, down from -11.0% several years earlier.

Nanalysis Scientific stock price

Access this data via the Eulerpool API

Nanalysis Scientific business model & stock analysis

Nanalysis Scientific Corp. is a capital pool company, which engages in the development and manufacture of portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The company is headquartered in Calgary, Alberta and currently employs 249 full-time employees. The company went IPO on 2017-06-29. The firm operates through four segments: Nanalysis, RS2D, K’Prime and Corporate. The Company’s subsidiaries include Nanalysis Corp., Nanalysis GmbH, RS2D S.A.S., One Moon Scientific (OMS), K'(Prime) Technologies Inc., KPrime Group USA, KPrime Technologies, Quad Systems AG and Quad Systems Ltd. RS2D S.A.S. is a technology company that is specialized in the designing of compact, electronics components for a range of precision analytical MR instruments, including both NMR and magnetic resonance imaging (MRI). OMS is a software company, which is specialized in a suite of software tools to streamline and automate magnetic resonance data analysis and management.

Frequently asked questions about Nanalysis Scientific

6 analysts currently rate the Nanalysis Scientific stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Nanalysis Scientific to generate revenue of 41.91 M CAD and earnings per share of -0.02 CAD.

Converted at the current exchange rate, the Nanalysis Scientific share trades at 0.07 EUR (0.11 CAD).

The expected revenue of Nanalysis Scientific is 41.91 M CAD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Nanalysis Scientific is -1.94 M CAD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Nanalysis Scientific is currently -5.76. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nanalysis Scientific stock.

The price-to-sales ratio (P/S) of Nanalysis Scientific is currently 0.27. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nanalysis Scientific stock.

The Eulerpool Quality Score for Nanalysis Scientific is 2/10.

The ISIN of Nanalysis Scientific is CA63000Y1034. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Nanalysis Scientific is A2PNDW. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Nanalysis Scientific is NSCI.V. The ticker symbol is used to trade Nanalysis Scientific shares on the stock exchange.

Fair ValueTerminal
0.09 CAD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
161,168.67 CAD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CAD
Initial public offering
Jun 29, 2017
ISIN
CA63000Y1034
Cusip
63000Y103
Market capitalization
15.23 M CADMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-5.76
P/Ee 2027
6.87
P/Ee 2028
1.37
P/S
P/Se
0.27
EV/EBIT
—
P/B Ratio
1.13
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-28.84 %
Last updated Oct 10, 2026, 10:37 PM

Nanalysis Scientific Peer Group

Nanalysis Scientific Ticker

OTC · NSCIF

Nanalysis Scientific FIGI

NSCI:CN · BBG00GFCCJH8NSCI:CV · BBG00GFCCJW1NSCI:CJ · BBG00GFCCK03NSCI:TV · BBG00GFCCK30NSCI:TG · BBG00GFCCK76NSCI:TK · BBG00GFCCK85NSCI:TW · BBG00GFCCK94NSCI:DV · BBG00GFCCKD9NSCI:DS · BBG00GFCCKF7NSCI:DG · BBG00GFCCKH5NSCI:QF · BBG00GFCCKJ3NSCI:QH · BBG00GFCCKK1